Crinetics PharmaceuticalsCRNX

那斯達克 · USD
49.31
+1.25
(+2.60%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.00
  • -
  • 0.01
  • 0.00
  • -
  • -
  • 0.00
  • 0.01
  • 0.00
icon
  • -63.12
  • -64.98
  • -
  • -
  • -37.66
  • -
  • -
  • -
  • 185.60
  • -86.13
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
143
1,031
361
-
-
399
640
-
346
988
營業成本
----------
營業毛利
143
1,031
361
-
-
399
640
-
346
988
營業費用
142,729130,143-94,745-83,182-62,65859,32353,983
研發費用
90,46480,30176,24066,56661,90558,34453,34145,58043,83940,640
推銷及管理費用
52,26549,84235,52628,17925,89224,83820,82817,07815,48413,343
非經常性項目費用
----------
其他營業費用
----------
營業利益
-142,586
-129,112
-111,405
-94,745
-87,797
-82,783
-73,529
-62,658
-58,977
-52,995
其他收入及費用
12,49513,47514,63114,15010,9698,7287,0696,7622,5162,016
利息費用
----------
稅前純益
-130,091
-115,637
-96,774
-80,595
-76,828
-74,055
-66,460
-55,896
-56,461
-50,979
所得稅
----------
稅後純益
-130,091
-115,637
-96,774
-80,595
-76,828
-74,055
-66,930
-60,097
-57,458
-50,979
基本每股稅後盈餘(元)
-1.38-1.23-1.04-0.88-0.96-0.94-0.93-0.90-1.01-0.94
稀釋每股稅後盈餘(元)
-1.39-1.23-1.04-0.87-0.96-0.93-0.93-0.88-1.02-0.94
基本平均股數(千股)
94215.0093791.0093102.0091494.0080091.0079008.0072289.0067146.0056808.0054275.00
稀釋平均股數(千股)
94215.0093791.0093102.0091494.0080091.0079008.0072289.0067146.0056808.0054275.00
還原基本每股稅後盈餘(元)
-1.38-1.23-1.04-0.88-0.96-0.94-0.93-0.90-1.01-0.94
還原稀釋每股稅後盈餘(元)
-1.39-1.23-1.04-0.87-0.96-0.93-0.93-0.88-1.02-0.94
還原基本平均股數(千股)
94,21593,79193,10291,49480,09179,00872,28967,14656,80854,275
還原稀釋平均股數(千股)
94,21593,79193,10291,49480,09179,00872,28967,14656,80854,275
EBITDA(千元)
-132,680-119,392-100,225-83,970-79,571-76,710-70,303-63,419-58,431-51,610

大家都在看

HOT